SFX by Ex Libris Inc.

Title:	Bayesian cost-effectiveness analysis from clinical trial data
Source:	Statistics in Medicine [0277-6715] O'Hagan, Anthony yr:2001

Basic

Full text

Full text available via Wiley Online Library All Journals

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library STM 2011

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Nixon, Richard M. "Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared." Health economics 19.3 (2010): 316-333.
description	2.	SPIEGELHALTER, D. "BAYESIAN APPROACHES TO RANDOMIZED TRIALS." Journal of the Royal Statistical Society. Series A. Statistics in society 157.3 (1994): 357-387.
description	3.	O'Hagan A, O'A. "Bayesian assessment of sample size for clinical trials of." Medical decision making 21.3 (2001): 219-30.
description	4.	O'Hagan, A. "Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies." Statistical methods in medical research 11.6 (2002): 469-490.
description	5.	Berndt, E R R. "Comparing SSRI treatment costs for depression using retrospective claims data: the role of nonrandom selection and skewed data." Value in health 3.3 (2000): 208-21.
description	6.	O'Hagan, A. "Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio." PharmacoEconomics 17.4 (2000): 339-349.
description	7.	O'Hagan, A. "A framework for cost-effectiveness analysis from clinical trial data." Health economics 10.4 (2001): 303-315.
description	8.	Barber, J A A. "Analysis of cost data in randomized trials: an application of the non-parametric bootstrap." Statistics in medicine 19.23 (2001): 3219-36.
description	9.	Qiu, Bao-Yue Y. "Meta-analysis of Selective Serotonin Reuptake Inhibitors (SSRIs) Compared to Tricyclic Antidepressants (TCAs) in the Efficacy and Safety of Anti-depression Therapy in Parkinson᾽ s Disease (PD) Patients." Iranian journal of pharmaceutical research 13.4 (2014): 1213-9.
description	10.	Catherine, H. "Effects of Omitting Covariates in Cox's Model for Survival Data." Scandinavian journal of statistics, theory and applications 15.2 (1988): 125-138.
description	11.	O'Hagan A, O'A. "Inference for the cost-effectiveness acceptability curve and." PharmacoEconomics 17.4 (2000): 339-.
description	12.	Anderson, G. "Design of the Women's Health Initiative Clinical Trial and Observational Study." Controlled Clinical Trials 19.1 (1998): 61-109.
description	13.	Al, MJ. "A Bayesian approach to economic analyses of clinical trials: the case of." Health economics (2000): 599-609.
description	14.	Spiegelhalter, D J J. "Bayesian methods for cluster randomized trials with continuous responses." Statistics in medicine 20.3 (2001): 435-52.
description	15.	Joseph, VR. "A Bayesian approach to the design and analysis of fractionated experiments." Technometrics 48.2 (2006): 219-229.
description	16.	Bose, I. "Business data mining Ð a machine learning perspective." Information & management 39 (2001): 211-.
description	17.	O'Hagan, A. "Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?" Health economics 12.1 (2002): 33-49.
description	18.	Manca, Andrea, M. "Estimating Mean QALYs in Trial-Based Cost-Effectiveness Analysis: The Importance of Controlling for Baseline Utility." Health economics 14.5 (2005): 487-496.
description	19.	van Asselt, van D. "Difficulties in Calculating Productivity Costs: Work Disability Associated with Borderline Personality Disorder." Value in health 11.4 (2008): 637-644.
description	20.	Knottnerus, Knottnerus A. "More is not always better: Cost-effectiveness analysis of combined, single behavioral and single physical rehabilitation programs for chronic low back pain." European journal of pain 13.1 (2008): 71-81.